Showing results (191-200 of 348) with videos related to
Sort By:
Pageof 35
Cell Reports|August 16, 2014
Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitorsMartin L Sos, Rebecca S Levin, John D Gordan, et al.Nature Machine Intelligence|October 24, 2022
Trans-channel fluorescence learning improves high-content screening for Alzheimer's disease therapeuticsDaniel R Wong, Jay Conrad, Noah Johnson, et al.Nature Methods|October 12, 2010
A human MAP kinase interactomeSourav Bandyopadhyay, Chih-yuan Chiang, Jyoti Srivastava, et al.Biochemical and Biophysical Research Communications|September 8, 2009
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sitesElisa Greggio, Jean-Marc Taymans, Eugene Yuejun Zhen, et al.Journal of Neurochemistry|November 16, 2010
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutantVeronique Daniëls, Renée Vancraenenbroeck, Bernard M H Law, et al.Nature Chemical Biology|June 27, 2018
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancerHayley J Donnella, James T Webber, Rebecca S Levin, et al.Annals of Clinical and Translational Neurology|November 3, 2021
Transcriptome analysis of collagen VI-related muscular dystrophy muscle biopsiesEleonora Guadagnin, Payam Mohassel, Kory R Johnson, et al.Expert Opinion on Drug Discovery|March 14, 2013
Animal models for drug discovery in dystoniaHa Jinnah, Angelika Richter, Jonathon W Mink, et al.The Biochemical Journal|August 14, 2013
Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycleEvy Lobbestael, Jing Zhao, Iakov N Rudenko, et al.Journal of Neurochemistry|January 14, 2010
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2Cindy H Hsu, Diane Chan, Elisa Greggio, et al.Pageof 35